Schedule 13G ownership disclosure

Tonix Pharmaceuticals Holding Corp.

Security class unavailable · CUSIP: 890260201

Event date: 2016-10-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,250,000
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-154893
Form type
SC 13G
Filer
CVI Investments, Inc.
CIK
CIK 1649553
Filed
Nov 04, 2016
Reporting period
Oct 26, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub